Evogene Q2 2025 Earnings Preview: EPS and Revenue Estimates Ahead of August 19th Release
ByAinvest
Monday, Aug 18, 2025 12:41 pm ET1min read
EVGN--
Over the past two years, Evogene has shown a consistent trend of beating EPS estimates, with a success rate of 75% and a revenue estimate beat rate of 63% [1]. In Q1 2025, the company reported an EPS of -$0.38, which exceeded analysts' consensus estimates by $0.12, while revenue was $2.44 million, below the consensus estimate of $4.42 million [2].
The upcoming earnings announcement is expected to provide insights into Evogene's financial performance for the second quarter of 2025. Investors will be closely watching for any updates on the company's strategic initiatives, financial health, and future growth prospects. The conference call is scheduled for 9:00 AM ET on August 19, with transcripts and audio expected to be available shortly thereafter [2].
References:
[1] https://seekingalpha.com/news/4486643-evogene-q2-2025-earnings-preview
[2] https://www.marketbeat.com/stocks/NASDAQ/EVGN/earnings/
Evogene is set to announce Q2 2025 earnings on August 19th. The consensus EPS estimate is -$0.63, a 40.6% YoY increase, while the revenue estimate is $0.93M, a 2.2% YoY increase. Over the past two years, Evogene has reported an average EPS of -$0.36 and an average revenue of $0.92M.
Evogene (NASDAQ:EVGN) is scheduled to announce its Q2 2025 earnings results on Tuesday, August 19, before the market opens. The consensus earnings per share (EPS) estimate stands at -$0.63, representing a 40.6% year-over-year (YoY) increase, while the consensus revenue estimate is $0.93 million, a 2.2% YoY increase [1].Over the past two years, Evogene has shown a consistent trend of beating EPS estimates, with a success rate of 75% and a revenue estimate beat rate of 63% [1]. In Q1 2025, the company reported an EPS of -$0.38, which exceeded analysts' consensus estimates by $0.12, while revenue was $2.44 million, below the consensus estimate of $4.42 million [2].
The upcoming earnings announcement is expected to provide insights into Evogene's financial performance for the second quarter of 2025. Investors will be closely watching for any updates on the company's strategic initiatives, financial health, and future growth prospects. The conference call is scheduled for 9:00 AM ET on August 19, with transcripts and audio expected to be available shortly thereafter [2].
References:
[1] https://seekingalpha.com/news/4486643-evogene-q2-2025-earnings-preview
[2] https://www.marketbeat.com/stocks/NASDAQ/EVGN/earnings/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet